B. Gertz

620 total citations
12 papers, 471 citations indexed

About

B. Gertz is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, B. Gertz has authored 12 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Physiology. Recurrent topics in B. Gertz's work include Bone health and treatments (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). B. Gertz is often cited by papers focused on Bone health and treatments (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). B. Gertz collaborates with scholars based in United States, Germany and Sweden. B. Gertz's co-authors include R.G.G. Russell, Jiunn H. Lin, Gail Murphy, H Malchow, William J. Polvino, David Krupa, Johan Svensson, John‐Olov Jansson, K. Cerchio and Daniel F. Wyss and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

B. Gertz

12 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Gertz United States	8	134	116	102	97	92	12	471
V. Martina Italy	13	163 1.2×	54 0.5×	108 1.1×	173 1.8×	74 0.8×	35	551
Dana A. Phares United States	18	346 2.6×	18 0.2×	19 0.2×	195 2.0×	96 1.0×	28	914
J.M.L. Stouthard Netherlands	5	188 1.4×	37 0.3×	49 0.5×	72 0.7×	12 0.1×	7	393
L. De Simone Italy	6	170 1.3×	72 0.6×	63 0.6×	259 2.7×	72 0.8×	6	544
Mehdi Ahmadian Iran	14	131 1.0×	27 0.2×	57 0.6×	38 0.4×	7 0.1×	35	415
Isao Hirayama Japan	12	132 1.0×	137 1.2×	26 0.3×	32 0.3×	3 0.0×	21	618
Mutsuko Nagata Japan	10	69 0.5×	40 0.3×	8 0.1×	101 1.0×	51 0.6×	13	358
Chien‐Wen Chou Taiwan	11	93 0.7×	14 0.1×	25 0.2×	122 1.3×	12 0.1×	21	365
Michael Rosenbaum United States	12	169 1.3×	22 0.2×	87 0.9×	234 2.4×	8 0.1×	30	686
Seong Bin Hong South Korea	13	83 0.6×	17 0.1×	16 0.2×	135 1.4×	8 0.1×	39	416

Countries citing papers authored by B. Gertz

Since Specialization

Citations

This map shows the geographic impact of B. Gertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Gertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Gertz more than expected).

Fields of papers citing papers by B. Gertz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Gertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Gertz. The network helps show where B. Gertz may publish in the future.

Co-authorship network of co-authors of B. Gertz

This figure shows the co-authorship network connecting the top 25 collaborators of B. Gertz. A scholar is included among the top collaborators of B. Gertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Gertz. B. Gertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Gertz, B., et al.. (2004). Review About Ginkgo Biloba Special Extract EGb 761 (Ginkgo). Current Pharmaceutical Design. 10(3). 261–264. 104 indexed citations

Hecken, Anne Van, Inge De Lepeleire, Peggy Wong, et al.. (2003). Platelet aggregation inhibition by naproxen, rofecoxib, diclofenac, ibuprofen, and meloxicam. Clinical Pharmacology & Therapeutics. 73(2). 1 indexed citations

Malchow, H, et al.. (2002). A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis. Alimentary Pharmacology & Therapeutics. 16(3). 415–423. 38 indexed citations

Ehrich, Elliot, D Hilliard, Arturo G. Porras, et al.. (1999). Demonstration of specific COX-2 inhibition by MK-966 in humans with supratherapeutic doses. Clinical Pharmacology & Therapeutics. 65(2). 164–164. 6 indexed citations

Schwartz, Jules I., Arturo G. Porras, Patrick Larson, et al.. (1999). Influence of antacids on the bioavailability (F) of a specific cyclooxygenase (COX)-2 inhibitor, MK-0966 (M) in the elderly. Clinical Pharmacology & Therapeutics. 65(2). 173–173. 5 indexed citations

Lin, Jiunn H., R.G.G. Russell, & B. Gertz. (1999). Pharmacokinetics of alendronate: an overview.. PubMed. 101. 18–26. 75 indexed citations

Svensson, Johan, Lars Lönn, John‐Olov Jansson, et al.. (1998). Two-Month Treatment of Obese Subjects with the Oral Growth Hormone (GH) Secretagogue MK-677 Increases GH Secretion, Fat-Free Mass, and Energy Expenditure¹. The Journal of Clinical Endocrinology & Metabolism. 83(2). 362–369. 125 indexed citations

Svensson, Johan, Claes Ohlsson, John‐Olov Jansson, et al.. (1998). Treatment with the Oral Growth Hormone Secretagogue MK-677 Increases Markers of Bone Formation and Bone Resorption in Obese Young Males. Journal of Bone and Mineral Research. 13(7). 1158–1166. 30 indexed citations

Holland, Sherry D., et al.. (1996). Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy.. PubMed. 108(3). 230–8. 33 indexed citations

10.

Schwändt, P., et al.. (1994). Safety and efficacy of lifibrol upon four-week administration to patients with primary hypercholesterolaemia. European Journal of Clinical Pharmacology. 47(2). 133–8. 7 indexed citations

11.

Budayr, Amer, D. Thiébaud, Patrick Ammann, et al.. (1994). Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein. Journal of Bone and Mineral Research. 9(4). 521–526. 12 indexed citations

12.

Jahnen, Andrea, et al.. (1992). Dietary fibre: the effectiveness of a high bran intake in reducing renal calcium excretion. Urological Research. 20(1). 3–6. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact